Article Information
History
- October 16, 2023.
Article Versions
- Version 1 (October 3, 2023 - 18:49).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Trishna Rathod-Mistry, PhD1,*,
- Eng Hooi Tan, PhD1,*,
- Victoria Y Strauss, PhD1,
- James O’Kelly, PhD2,
- Francesco Giorgianni2,
- Richard Baxter2,
- Vanessa C Brunetti2,
- Alma Becic Pedersen, MD, PhD3,
- Vera Ehrenstein, DSc3 and
- Daniel Prieto-Alhambra, MD, PhD1,4,+
- 1Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
- 2Amgen Ltd, Uxbridge, UK
- 3Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
- 4Department of Medical Informatics, Erasmus University Medical Centre, Rotterdam, The Netherlands
- ↵+Corresponding author: Daniel Prieto-Alhambra, Address: Botnar Research Centre Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, OX3 7LD, UK, Telephone: +44 (0)1865 223725, Email: daniel.prietoalhambra{at}ndorms.ox.ac.uk
Posted October 16, 2023.
Evaluating the comparability of osteoporosis treatments using propensity score and negative control outcome methods in UK and Denmark electronic health record databases
